Several companies, including Pfizer, are developing antiviral drugs that could halt the progression of COVID-19 symptoms or prevent the onset of disease for close contacts of people with infections. Theoretically, the therapeutics would be another tool used to fight the coronavirus alongside vaccines.
Former Food and Drug Administration Commissioner Scott Gottlieb is confident there will be some successes, noting that the coronavirus isn't "a hard virus to drug in terms of how it replicates." But there is a bit of a race against the clock on this issue, although the reason for that probably won't be the worst thing you've heard since the pandemic began.
It's becoming more difficult to find "virus naive" patients in the United States, Gottlieb said during an appearance on MSNBC's Squawk Box on Monday. Because so many people have either been vaccinated or had a previous infection, it's increasingly challenging to find enough people who don't have some form of immunity to enroll in trials to determine the efficacy of the drug treatments. Watch Gottlieb's explanation below.
The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
-
House posts lewd Epstein note attributed to TrumpSpeed Read The estate of Jeffrey Epstein turned over the infamous 2003 birthday note from President Donald Trump
-
Supreme Court allows 'roving' race-tied ICE raidsSpeed Read The court paused a federal judge's order barring agents from detaining suspected undocumented immigrants in LA based on race
-
Why can't France hold on to its prime ministers?Today's Big Question Spiralling debt, ageing population and cultural refusal to accept budget cuts – despite high welfare spending – have been turbocharged by Emmanuel Macron
-
Texas declares end to measles outbreakSpeed Read The vaccine-preventable disease is still spreading in neighboring states, Mexico and Canada
-
RFK Jr. shuts down mRNA vaccine funding at agencySpeed Read The decision canceled or modified 22 projects, primarily for work on vaccines and therapeutics for respiratory viruses
-
Measles cases surge to 33-year highSpeed Read The infection was declared eliminated from the US in 2000 but has seen a resurgence amid vaccine hesitancy
-
Kennedy's vaccine panel signals skepticism, changeSpeed Read RFK Jr.'s new vaccine advisory board intends to make changes to the decades-old US immunization system
-
Kennedy ousts entire CDC vaccine advisory panelspeed read Health Secretary RFK Jr. is a longtime anti-vaccine activist who has criticized the panel of experts
-
RFK Jr. scraps Covid shots for pregnant women, kidsSpeed Read The Health Secretary announced a policy change without informing CDC officials
-
New FDA chiefs limit Covid-19 shots to elderly, sickspeed read The FDA set stricter approval standards for booster shots
-
US overdose deaths plunged 27% last yearspeed read Drug overdose still 'remains the leading cause of death for Americans aged 18-44,' said the CDC
